Retatrutide 40mg | 10-Vial Kit | 400mg Total | Triple Agonist GIP/GLP-1/Glucagon

Description

What is Retatrutide 40mg?

Retatrutide is the most potent weight-reduction compound currently in clinical development — a triple GLP-1R/GIPR/GCGR agonist producing 24.2% mean body weight reduction at 48 weeks in Phase 2 trials (the highest of any pharmacological compound in human clinical research). The 40mg/vial format provides a high-dose configuration suited for intensive research protocols. GLP-1R provides appetite suppression; GIPR enhances insulin secretion and adipocyte effects; GCGR adds direct hepatic fat mobilisation, brown adipose thermogenesis, and energy expenditure independently of food intake.